Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer. - Cursano, M. C.; Conteduca, V.; Scarpi, E.; Gurioli, G.; Casadei, C.; Gargiulo, S.; Altavilla, A.; Lolli, C.; Vincenzi, B.; Tonini, G.; Santini, D.; De Giorgi, U. (Scientific Reports, 2022)